𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effects of dopamine agonists and antagonists on murine melanoma: Correlation with dopamine binding activity

✍ Scribed by Thomas M. Krummel; James P. Neifeld; Robert N. Taub


Publisher
John Wiley and Sons
Year
1982
Tongue
English
Weight
638 KB
Volume
49
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Effect of 3-PPP, a putative dopamine aut
✍ David T. Wong; Penny G. Threlkeld; Leroy R. Reid πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 467 KB

Effect of 3-PPP, a putative dopamine autoreceptor agonist, on [3H]ligand binding to dopamine receptors of calf and rat striatum. Drug Dev. Res. 3:177-184, 1983. 3-(3-Hydroxyphenyl)-N-n-propyliperidine (3-PPP) is most effective in inhibiting I3HJapomorphine binding in rat striatal membranes, with Ki

Effect of the putative dopamine D1 agoni
✍ L. Verhagen Metman; P. J. Blanchet; D. de Jong; M. M. Mouradian; Dr. T. N. Chase πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 433 KB

## Abstract The ergoline derivative FCE 23884 acts as a dopamine D~1~ agonist in untreated parkinsonian animals and as a D~2~ antagonist in animals whose dopamine system is intact or levodopa treated. To evaluate whether this dual action might benefit patients with Parkinson's disease (PD) who have

Effects of medial prefrontal cortical in
✍ Michael D. Doherty; Alain Gratton πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 177 KB πŸ‘ 1 views

Stress stimulates dopamine (DA) release in nucleus accumbens (NAcc) but will do so more strongly in medial prefrontal cortex (PFC). Evidence indicates, however, that the cortical DA response to stress acts to dampen the concurrent increase in NAcc DA release. In the present study, we used voltammetr

Long-term effects of a luteinizing hormo
✍ Shimizu, Akio πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 844 KB

An autumn-spawning bitterling, Acheilognathus rhombea, kept mainly under suppressive environmental conditions, was treated with an emulsified luteinizing hormone-releasing hormone (LHRH) analogue (LHRH-a) and/or a dopamine antagonist, pimozide (PIM), in various phases throughout the annual reproduct